tirzepatide conversion Compound Dosage Chart ML to Units Conversion for

Witting C, Langman CB, Assimos D, Baum MA, Kausz A, Milliner D, et al

Comorbidity documentation

GLP-1 semaglutideFLOW 24%SUSTAIN 6 liraglutidedulaglutide exenatidelixisenatide SGLT2 GLP-1 SGLT2 GLP-1 DPP-4 orforglipron eGFR GLP-1 FLOW semaglutide 24% semaglutideliraglutidedulaglutide SGLT2 GLP-1 GLP-1 GLP-1 receptor agonists-1 [1] [1][5] [1] [1]dulaglutide dulaglutide [4] -[1] 21%[3]eGFR 30% 22% 40% 24% 50% 28% 23%[2] [3] semaglutide SUSTAIN 6 36%[1] FLOW GLP-1 semaglutide 1 24%[5] SUSTAIN-6 semaglutide KDIGO 69% 29%[5] Liraglutide LEADER [1][4] Dulaglutide REWIND [1][4] Exenatide lixisenatide eGFR[3] ELIXAEXSCEL liraglutidesemaglutidedulaglutide[3] dulaglutideexenatideliraglutidesemaglutide [6]semaglutide dulaglutide 8% exenatide 12% dulaglutide 19%[6] eGFR SGLT2 GLP-1 SGLT2 eGFR 40% SGLT2 [7] DPP-4 GLP-1 [7] SGLT2 [7] eGFR [1][5] GLP-1 semaglutideliraglutidedulaglutide exenatidelixisenatide [3] orforglipron GLP-1 orforglipron SGLT2 GLP-1semaglutideliraglutidedulaglutideorforglipron SGLT2 [3] SGLT2 semaglutideFLOW 24%SUSTAIN 6 liraglutidedulaglutide exenatidelixisenatide SGLT2 GLP-1 SGLT2 GLP-1 DPP-4 orforglipron eGFR A better life begins with health Rosen CJ, Ingelfinger JR

Supports nerve health, brain clarity, and energy metabolismno conversion needed in the liver